Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabotropic Glutamate Receptor 3 (mGluR3) is a G-protein coupled receptor that modulates cell excitability and synaptic transmission. It is involved in neuroprotection by promoting glutamate uptake in astrocytes and limiting neurotoxic microglial phenotypes. Dysfunctions in mGluR3 signaling are linked to cognitive impairment and increased risk for psychiatric disorders such as schizophrenia, making it a potential therapeutic target for CNS disorders.
Gi/Go protein-coupled; inhibits cAMP cascade
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabotropic Glutamate Receptor Type 3 (mGluR3).